Unity Biotechnology appoints Tozier as Chief Strategy Officer

UNITY Biotechnology (UBX) announced the appointment of Alicia Tozier, MBA, as chief strategy officer. In this new role, she will develop and implement the company’s corporate and product strategies. Prior to joining UNITY, Tozier was senior vice president at Outlook Therapeutics (OTLK) where she drove organizational activation and go to market, scaling multiple global functions for the pre-commercial biopharmaceutical company’s global entry.